International Stem Cell Corp
OTC:ISCO
International Stem Cell Corp
OTC:ISCO
Price:
0.17
USD
Market Cap:
$1.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
International Stem Cell Corp
OTC:ISCO
|
US |
|
MindTree Ltd
NSE:MINDTREE
|
IN |
|
C
|
Com7 PCL
SET:COM7
|
TH |
|
Lithium Corp
LSE:0JVB
|
US |
|
C
|
Conrad Asia Energy Ltd
ASX:CRD
|
ID |
|
B
|
Bausch + Lomb Corp
F:S2L
|
CA |
|
H
|
Hargreaves Lansdown PLC
F:DMB
|
UK |
|
Haw Par Corporation Ltd
OTC:HAWPY
|
SG |
|
Sa Sa International Holdings Ltd
F:SSW
|
HK |
|
C
|
Concord New Energy Group Ltd
F:HK51
|
HK |
|
H
|
Heidelberger Druckmaschinen AG
DUS:HDD
|
DE |
|
Sands China Ltd
F:599A
|
MO |
|
V
|
Vale Indonesia Tbk PT
XMUN:XT3B
|
ID |
|
B
|
Bausch Health Companies Inc
DUS:BVF
|
CA |
|
O
|
OC Oerlikon Corporation AG Pfaeffikon
XMUN:OBH
|
CH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISCO's stock price target?
Not Available
ISCO does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for International Stem Cell Corp?
Projected CAGR
4%
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 7 years is 4%.
What is the Gross Profit forecast for International Stem Cell Corp?
Projected CAGR
6%
6%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 7 years is 6%.
